Liver Cirrhosis: Are implants an option?
This dental implant patient presented yesterday at the wax try in for the denture set up and informed me he was recently diagnosed with cirrhosis of the liver. (Source: Dental Implants Discussed by Experts)
Source: Dental Implants Discussed by Experts - January 24, 2017 Category: Dentistry Authors: osseonews Tags: Clinical Cases Surgical Source Type: news

Nuchal septations increase risk for fetal anomalies
Nuchal septations are a powerful independent risk factor for chromosomal fetal...Read more on AuntMinnie.comRelated Reading: Repeat fetal ultrasound screenings may be unnecessary Smoking adversely affects patellar, Achilles tendons 3D/4D ultrasound matures as it shows clinical value Contrast US boosts diagnostic power of breast ultrasound Spleen stiffness correlates with cirrhosis complication (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 19, 2017 Category: Radiology Source Type: news

Liver Cirrhosis Tied to Hepatocellular Cancer Recurrence Liver Cirrhosis Tied to Hepatocellular Cancer Recurrence
Compared with patients with a normal liver who undergo curative hepatectomy because of de novo hepatocellular carcinoma (HCC), those with liver cirrhosis may have a higher hepatocarcinogenic potential, researchers say.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - January 13, 2017 Category: Surgery Tags: Gastroenterology News Source Type: news

What Precautions Should A Childcare Center Take For A Child with Hepatitis C Infection?
Discussion It is estimated that 180 million people worldwide are infected with Hepatitis C (HCV) which includes ~11 million children. In the United States it is estimated that there were 30,500 acute HCV cases in 2014, and 2.7-3.9 million people with chronic HCV. Many infections are not identified. It is estimated that “…only 5-15% of HCV-infected children in the United States are identified.” Problems associated with HCV include acute hepatitis (including fever, malaise, dark-urine, abdominal pain, jaundice, appetite loss, nausea, emesis, clay-colored stools), acute fulminant hepatitis (not common in c...
Source: PediatricEducation.org - January 9, 2017 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Covert hepatic encephalopathy: can my patient drive? - Shaw J, Bajaj JS.
Liver cirrhosis is a public health problem and hepatic encephalopathy is one of its main complications, which can be either overt meaning thereby evident and readily diagnosed, or covert/minimal (covert hepatic encephalopathy-CHE) needing psychometric test... (Source: SafetyLit)
Source: SafetyLit - December 29, 2016 Category: Global & Universal Tags: Distraction, Fatigue, Chronobiology, Vigilance, Workload Source Type: news

NICE focuses on improving treatment and diagnosis of liver disease
Almost 1.9 million harmful drinkers in England could be sent for scans for cirrhosis by their GPs to detect disease early so treatment and lifestyle changes are more effective. (Source: NHS Networks)
Source: NHS Networks - December 20, 2016 Category: UK Health Source Type: news

Send ‘harmful drinkers’ for liver disease scans, GPs urged
Draft NICE quality standard aims to boost detection of cirrhosis and cancer Related items fromOnMedica Alcohol and the nervous system England faces 135,000 alcohol-related cancer deaths by 2035 A fifth of over-65s are drinking too much Foetal alcohol syndrome must be better recognised Exercise might partly compensate for drinking alcohol (Source: OnMedica Latest News)
Source: OnMedica Latest News - December 19, 2016 Category: UK Health Source Type: news

Liver disease: draft quality standard
National Institute for Health and Care Excellence (NICE) - NICE are seeking comments and feedback on the draft quality standard for the treatment and prevention of liver disease. The draft standard advises GPs to to send people for scans for cirrhosis if men are drinking more than 50 units per week or 22 pints and women are drinking more than 35 units per week or three and a half bottles of wine. The closing date for responses to the consultation is 2 February 2017.Draft quality standardConsultation documentsPress release (Source: The Kings Fund - Health Management Specialist Collection)
Source: The Kings Fund - Health Management Specialist Collection - December 19, 2016 Category: Health Management Authors: The King ' s Fund Information & Knowledge Service Tags: Consultations Local authorities, public health and health inequalities Source Type: news

The Impact of PPI Therapy on Patients With Liver Disease The Impact of PPI Therapy on Patients With Liver Disease
Are protein pump inhibitors being inappropriately prescribed to patients with cirrhosis?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 13, 2016 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Virus Eradication in Compensated HCV-Related Cirrhosis Virus Eradication in Compensated HCV-Related Cirrhosis
Is the achievement of a sustained viral response associated with a reduction in liver disease progression and liver-related mortality in patients with HCV-related cirrhosis?Liver International (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - December 13, 2016 Category: Transplant Surgery Tags: Gastroenterology Journal Article Source Type: news

New pathways to treat non-alcoholic fatty-liver disease discovered
Researchers have discovered a new pathway in the liver that opens the door to treat non-alcoholic fatty liver disease, a condition that affects up to 25 percent of the population and may lead to cirrhosis and eventually liver cancer or failure, and likely other liver diseases. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - December 10, 2016 Category: Science Source Type: news

Study finds new pathways to treat non-alcoholic fatty-liver disease
(University of South Carolina) Researchers from the University of South Carolina, Duke University, University of Alabama at Birmingham, and Metabolon Inc. Research Triangle Park have discovered a new pathway in the liver that opens the door to treat non-alcoholic fatty liver disease, a condition that affects up to 25 percent of the population and may lead to cirrhosis and eventually liver cancer or failure, and likely other liver diseases. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 9, 2016 Category: Global & Universal Source Type: news

Direct-acting Antivirals Treat HIV/HCV Coinfection in Real-world Study
Twelve-week viral eradication rates were high in patients coinfected with HCV and HIV, particularly in those without advanced cirrhosis. (Source: ConsultantLive)
Source: ConsultantLive - December 8, 2016 Category: Internal Medicine Authors: Mark L. Fuerst Tags: Hepatitis C Source Type: news

Advanced Cirrhosis Patients Respond to DAAs in Real-world Study
High sustained virologic response rates were seen among patients with decompensated cirrhosis in European compassionate care cohort. (Source: ConsultantLive)
Source: ConsultantLive - December 7, 2016 Category: Internal Medicine Authors: Mark L. Fuerst Tags: Hepatitis C Source Type: news

Zimbabwe: 8-Year-Old in Urgent Need of Liver Transplant
[The Herald] AN EIGHT-YEAR-OLD Masvingo baby is in urgent need of help to undergo a liver transplant in India as more minors continue to be diagnosed of severe Jaundice (Liver Cirrhosis and Biliary Atresia).Thayel Makatendeka Botsa (pictured right with her mother) requires $50 000 to cover medication and travel expenses. The baby's mother Mrs Adelaide Botse said Thayel was first diagnosed of severe Jaundice soon after her birth in March this year. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - December 7, 2016 Category: African Health Source Type: news

Living With Cancer: Hepatocellular carcinoma
Hepatocellular carcinoma Hepatocellular carcinoma is the most common type of primary liver cancer. Hepatocellular carcinoma occurs most often in people with chronic liver diseases, such as cirrhosis caused by hepatitis B or hepatitis C infection. Fight the flu bug by keeping hands clean During and after cancer treatment, it's common to feel vulnerable to colds [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - December 1, 2016 Category: Databases & Libraries Source Type: news

Janssen begins Phase IIb study of drug combination to treat hepatitis C virus infection
Janssen Research& Development has begun its Phase IIb study of combination of simeprevir, odalasvir and AL-335 to treat chronic hepatitis C virus infection without cirrhosis. (Source: Drug Development Technology)
Source: Drug Development Technology - November 29, 2016 Category: Pharmaceuticals Source Type: news

The Development of Comorbid Diseases in Alcoholic Cirrhosis The Development of Comorbid Diseases in Alcoholic Cirrhosis
Alcoholic cirrhosis is known to promote development of several comorbid diseases, from cardiovascular disease to various cancers--but are patients living long enough to develop them?Liver International (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 23, 2016 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Diet and exercise can improve kidney function in patients with fatty liver disease
(Wiley) Non-alcoholic steatohepatitis (NASH) is a potentially serious liver condition characterized by excess fat in the liver associated with inflammation and scarring. NASH may progress to cirrhosis of the liver and liver cancer, and it can also compromise kidney function. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 21, 2016 Category: Global & Universal Source Type: news

Cenicriviroc Improves Fibrosis in Patients With Fatty Liver Cenicriviroc Improves Fibrosis in Patients With Fatty Liver
The investigational drug is designed to interrupt the inflammatory cascade that leads to fibrosis and cirrhosis in patients with severe nonalcoholic steatohepatitis (NASH).Medscape Medical News (Source: Medscape Gastroenterology Headlines)
Source: Medscape Gastroenterology Headlines - November 19, 2016 Category: Gastroenterology Tags: Gastroenterology News Source Type: news

CMS to Pay for Leadless Pacemakers in Studies; HF Alerts From Devices; Statins for Cirrhosis?
(MedPage Today) -- Cardiovascular Daily wraps up the top cardiology news of the week (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - November 18, 2016 Category: Primary Care Source Type: news

Outreach to cirrhosis patients doubles early screening rates for deadly liver cancer
(UT Southwestern Medical Center) Proactive outreach to cirrhosis patients in a safety net health system successfully doubled their screening rates for liver cancer, UT Southwestern Medical Center researchers found. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 18, 2016 Category: Cancer & Oncology Source Type: news

Mortality Risk Halved With Statin Use in Alcoholic Cirrhosis Mortality Risk Halved With Statin Use in Alcoholic Cirrhosis
Statins reduced mortality risk for patients with compensated and decompensated alcoholic cirrhosis in a retrospective study, and also reduced the risk for decompensation.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 15, 2016 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Statins Tied to Lower Death Rate in Alcoholic Cirrhosis (CME/CE)
(MedPage Today) -- Mortality rate lowered by up to 55% in Danish study (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - November 14, 2016 Category: Gastroenterology Source Type: news

NAFLD Cirrhosis Seems to Run in Families (CME/CE)
(MedPage Today) -- Study suggests screening liver disease patients'first-degree relatives (Source: MedPage Today Gastroenterology)
Source: MedPage Today Gastroenterology - November 13, 2016 Category: Gastroenterology Source Type: news

Direct-Acting Antivirals for Hep C Might Worsen Liver Cancer Direct-Acting Antivirals for Hep C Might Worsen Liver Cancer
For patients with hepatitis C and cirrhosis who develop hepatocellular carcinoma during treatment or follow-up, there is a trend toward disease worsening, new research shows.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 13, 2016 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

Fibrosis Risk High in Kids With Transplanted Livers (CME/CE)
(MedPage Today) -- Those with cirrhosis at risk of liver failure and graft loss (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - November 12, 2016 Category: Primary Care Source Type: news

Statin Drugs Reduce Progression to Cirrhosis in HIV/HCV Statin Drugs Reduce Progression to Cirrhosis in HIV/HCV
The use of statins may help reduce liver disease progression among coinfected patients, a new study reports.AIDS (Source: Medscape Hiv-Aids Headlines)
Source: Medscape Hiv-Aids Headlines - November 11, 2016 Category: Infectious Diseases Tags: HIV/AIDS Journal Article Source Type: news

Bristol-Myers Squibb Signs Exclusive Worldwide License Agreement with Nitto Denko for Targeted siRNA Therapy in Advanced Non-alcoholic Steatohepatitis (NASH) and Cirrhosis Due to NASH
NEW YORK & OSAKA, Japan--(Healthcare Sales & Marketing Network)--Bristol-Myers Squibb Company (BMY) and Nitto Denko Corporation (Nitto) (6988:Tokyo) today announced the companies have entered into an agreement granting Bristol-Myers Squibb exclusive worldw... Biopharmaceuticals, Licensing Bristol-Myers Squibb, Nitto Denko (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - November 10, 2016 Category: Pharmaceuticals Source Type: news

Smoking adversely affects patellar, Achilles tendons
Need another reason to quit or never start smoking cigarettes? B-mode ultrasound...Read more on AuntMinnie.comRelated Reading: Contrast US boosts diagnostic power of breast ultrasound Echo reveals why smoking ups risk of heart failure Spleen stiffness correlates with cirrhosis complication Shear-wave elastography aids monitoring of tendinopathy US elastography offers clues to middle-age Achilles injury risk (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 3, 2016 Category: Radiology Source Type: news

Preventing Cirrhosis in Hepatitis C With Fibrosis Preventing Cirrhosis in Hepatitis C With Fibrosis
Are direct-acting anti-virals cost-effective treatment for patients with HCV infection with liver fibrosis who are at high risk of progression to cirrhosis?Alimentary Pharmacology & Therapeutics (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - November 3, 2016 Category: Surgery Tags: Gastroenterology Journal Article Source Type: news

Improve Kidney Function With IV Laser Treatment
If you're one of the more than 20 million Americans who suffer from chronic kidney disease (CKD), your doctor has probably told you there isn't much they can do for you. Mainstream medicine doesn't have a cure for CKD. What they do have is a lot of drugs to treat the symptoms of it. And most of the drugs will leave you worse off than before you started taking them… Like ESAs, which are prescribed to treat anemia caused by chronic kidney disease. These dangerous drugs can cause strokes, heart attacks, blood clots and seizures. And if your kidneys fail, your only options are dialysis or a kidney transplant...
Source: Al Sears, MD Natural Remedies - October 31, 2016 Category: Complementary Medicine Authors: Cathy Card Tags: Anti-Aging Source Type: news

In Refractory Ascites, TIPS With Covered Stents Helps Avoid Transplant In Refractory Ascites, TIPS With Covered Stents Helps Avoid Transplant
Transjugular intrahepatic portosystemic shunting (TIPS) with covered stents prolongs transplant-free survival in cirrhosis patients with recurrent ascites, researchers from France report.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - October 4, 2016 Category: Surgery Tags: News Source Type: news

HCV Eradication, Gut Dysbiosis, and Inflammation in Cirrhosis HCV Eradication, Gut Dysbiosis, and Inflammation in Cirrhosis
This study aimed to determine the impact of sustained virological response on gut dysbiosis and systemic inflammation in patients with cirrhosis due to HCV.Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 4, 2016 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

PPI Use and Risk of Hepatic Encephalopathy in Cirrhotic Patients PPI Use and Risk of Hepatic Encephalopathy in Cirrhotic Patients
Patients with cirrhosis who are treated with a proton pump inhibitor (PPI) face an increased risk of hepatic encephalopathy, and the risk rises in a dose-dependent fashion, a large study from Taiwan has found.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 23, 2016 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

BioVie's Lead Compound BIV201 Receives FDA Orphan-Drug Designation for the Treatment of Ascites
BEVERLY, MA--(Healthcare Sales & Marketing Network) - BioVie Inc. (OTC PINK: BIVI) (the "Company"), a development-stage company focused on the discovery, development, and commercialization of innovative drug therapies, announced today that the Fo... Biopharmaceuticals, FDA BioVie, ascites, cirrhosis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 9, 2016 Category: Pharmaceuticals Source Type: news

Spleen stiffness correlates with cirrhosis complication
The progression of thrombocytopenia, or blood platelet deficiency, in cirrhotic...Read more on AuntMinnie.comRelated Reading: Can elastography help guide breast cancer treatment? Shear-wave elastography can predict esophageal varices Fans of contrast ultrasound celebrate FDA approval Quantitative ultrasound method stages fatty liver Panel says elastography has value for liver fibrosis (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 2, 2016 Category: Radiology Source Type: news

Most Popular NEJM Group Feature This Week: Cirrhosis Review (FREE)
By the Editors Here's the most clicked-on item we featured from NEJM Group this … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - September 1, 2016 Category: Primary Care Source Type: news

Your NEJM Group Today: Cirrhosis Review, Chest Pain Rule Out, Florida FM/IM Opportunity (FREE)
By the Editors NEJM Group offers so many valuable resources for practicing clinicians. Here's what we chose for you today:NEJM Clinical Practice Center: Review: This guide … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - August 28, 2016 Category: Primary Care Source Type: news

Non-Alcoholic Fatty Liver Disease
I’m seeing a disturbing trend in my practice. More and more people are coming in with a deadly liver condition. In medical school I was taught that liver disease was limited to hardcore drinkers. But the people I’m seeing aren’t heavy drinkers. Some don’t drink at all. It’s one of the fastest-growing health epidemics in the world. And here’s the tragedy. Mainstream medicine has no effective drug or other treatment for this condition. What is NAFLD? I’m talking about non-alcoholic fatty liver disease (NAFLD). NAFLD causes serious liver problems. It results in painful swelling and sc...
Source: Al Sears, MD Natural Remedies - August 15, 2016 Category: Complementary Medicine Authors: Al Sears Tags: Health Source Type: news

A Cure For Hepatitis C: Bringing Medication Within Reach For All
The Promise and the Challenge Here's the promise: There is a cure, a complete cure in a short 12 weeks, for hepatitis C virus (HCV), which the Centers for Disease Control and Prevention estimates afflicts between 2.7 and 3.9 million Americans, and which is a leading cause of liver cancer and other devastating health complications. This new class of HCV drugs, which are much easier on the human body and virtually free of side effects, attacks the virus directly and can reduce the viral load to zero when taken correctly. As with so many things in healthcare, this promise comes with challenges. First, the price tag can be s...
Source: Healthy Living - The Huffington Post - August 12, 2016 Category: Consumer Health News Source Type: news

Chronic Liver Disease Patterns Differ by Ethnicity Chronic Liver Disease Patterns Differ by Ethnicity
The patterns of chronic liver disease (CLD) and cirrhosis and their underlying causes differ by ethnicity, according to results from the Multiethnic Cohort (MEC). Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 29, 2016 Category: Consumer Health News Tags: Gastroenterology News Source Type: news

PBC can present asymptomatically in elderly patients
An 83-year-old woman who was admitted to an emergency department for unsteadiness and dizziness was eventually diagnosed with primary biliary cirrhosis (PBC), according to a case report by Patrice... (Source: Family Practice News)
Source: Family Practice News - July 28, 2016 Category: Primary Care Source Type: news

Focusing on patients and progress on World Hepatitis Day
World Hepatitis Day is a unique opportunity to take stock of the recent advancements in new treatments and cures to combat versions of hepatitis. Founded by the World Hepatitis Alliance, World Hepatitis Day brings awareness to the five hepatitis viruses that cause inflammation of the liver. This year ’s theme for the global campaign is “Elimination.” With hepatitis being the leading cause of cirrhosis and liver cancer, the disease is the most common reason for a liver transplant in the United States, according to the Centers for Disease Control and Prevention . (Source: The Catalyst)
Source: The Catalyst - July 28, 2016 Category: Pharmaceuticals Tags: chronic disease Hepatitis C Advances in Science infectious diseases Source Type: news

Focusing on patients and progress on World Hepatitis Day
World Hepatitis Day is a unique opportunity to take stock of the recent advancements in new treatments and cures to combat versions of hepatitis. Founded by the World Hepatitis Alliance, World Hepatitis Day brings awareness to the five hepatitis viruses that cause inflammation of the liver. This year ’s theme for the global campaign is “Elimination.” With hepatitis being the leading cause of cirrhosis and liver cancer, the disease is the most common reason for a liver transplant in the United States, according to the Centers for Disease Control and Prevention . (Source: The Catalyst)
Source: The Catalyst - July 28, 2016 Category: Pharmaceuticals Tags: chronic disease Hepatitis C Advances in Science infectious diseases Source Type: news

' Screen-and-treat' scheme for hepatitis B may prevent deadly complications
Research into Africa ’s first ‘screen-and-treat’ program for hepatitis B suggests the initiative may reduce deadly complications of the virus. The hepatitis B virus infects around 250 million people worldwide, and is transmitted through blood and bodily fluids. It is commonly transferred from mother to baby during birth. However the virus causes no immediate symptoms, and can remain silent in the body for decades until triggering severe complications such as liver damage (cirrhosis) and cancer. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - July 27, 2016 Category: Science Source Type: news

CHMP Grants Positive Opinion for Shorter Treatment Duration with AbbVie's VIEKIRAX(R) (ombitasvir/paritaprevir/ritonavir tablets) for Patients with Genotype 4 Chronic Hepatitis C with Compensated Cirrhosis (Child-Pugh A)
NORTH CHICAGO, Ill., July 25, 2016 -- (Healthcare Sales & Marketing Network) -- AbbVie (ABBV), a global biopharmaceutical company, announced today that the European Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has... Biopharmaceuticals, RegulatoryAbbVie, hepatitis C, VIEKIRAX (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 25, 2016 Category: Pharmaceuticals Source Type: news

Fighting life-threatening bacteria without antibiotics
Patients suffering from liver cirrhosis often die of life-threatening bacterial infections. In these patients the immune cells are unable to eliminate the bacterial infections. Scientist have now discovered that type I IFN released by immune cells due to increased migration of gut bacteria into the cirrhotic liver incapacitate the immune system. Based on their findings, such infections can be contained by strengthening the immune response -- without antibiotics. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - July 19, 2016 Category: Science Source Type: news

Fighting life-threatening bacteria without antibiotics
(University of Bonn) Patients suffering from liver cirrhosis often die of life-threatening bacterial infections. In these patients the immune cells are unable to eliminate the bacterial infections. Scientist at the University of Bonn and TU Munich have now discovered that type I IFN released by immune cells due to increased migration of gut bacteria into the cirrhotic liver incapacitate the immune system. Based on their findings, such infections can be contained by strengthening the immune response -- without antibiotics. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 19, 2016 Category: Infectious Diseases Source Type: news

Liver diseases exhibit differing patterns in ethnic minorities
(Wiley) Chronic liver disease (CLD) and cirrhosis are serious liver conditions but little is known about how they affect ethnic minority populations in the United States. When researchers examined CLD and cirrhosis among different groups, they found that the prevalence of CLD ranged from 3.9 percent in African-Americans and Native Hawaiians to 4.1 percent in whites, 6.7 percent in Latinos, and 6.9 percent in Japanese. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - July 19, 2016 Category: Global & Universal Source Type: news